Skip to content

Effect of Protein and Carbohydrate Supplementation Associated with Resistance Exercise as a Treatment for Type 2 Diabetes Mellitus

Effect of Protein and Carbohydrate Supplementation Associated with Resistance Exercise as an Adjunct in the Treatment of Type 2 Diabetes Mellitus: A Randomized, Triple-Blind Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2m7w87r
Enrollment
Unknown
Registered
2025-06-30
Start date
2024-01-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

exercise

Interventions

This randomized, triple-blind clinical trial will include 39 men with type 2 diabetes mellitus (T2DM), aged 65-79 years, with a body mass index (BMI) of 22-32 kg/m², randomly assigned to three groups:
G07.203.300.456

Sponsors

Universidade São Judas Tadeu
Lead Sponsor
Faculdade de Medicina da Universidade de São Paulo
Collaborator

Eligibility

Sex/Gender
Male
Age
65 Years to 79 Years

Inclusion criteria

Inclusion criteria: Diabetes Mellitus type 2 (DMT2) with a stable medication dose (oral antidiabetics, insulin, or a combination of both) for three or more months; glycated hemoglobin between 6% and 9.0%; renal function assessed by the Modification of Diet in Renal Disease (MDRD) above 60 ml/h; no untreated or decompensated chronic non-communicable disease; male sex; age between 65 and 79 years

Exclusion criteria

Exclusion criteria: Inability to undergo assessments and reassessments; having more than three absences during the training period

Design outcomes

Primary

MeasureTime frame
It is expected to find an improvement in muscle strength, measured by isokinetic knee assessment (in Joules) and handgrip strength (in kg/f), as well as an improvement in the glycemic profile, assessed through biochemical analysis of glucose (mg/dL), fructosamine (µmol/L), glycated hemoglobin (%), insulin (µU/mL), homeostatic model assessment for insulin resistance (HOMA-IR), and C-peptide (ng/mL)

Secondary

MeasureTime frame
Progression of muscle strength measured by one-repetition maximum, muscle thickness (mm), body composition: lean mass (kg) and fat mass (kg and %); lipid profile measured by biochemical analysis: low-density lipoprotein (LDL) (mg/dL), high-density lipoprotein (HDL)(mg/dL),very low-density lipoprotein (VLDL) (mg/dL), triglycerides (mg/dL), cholesterol (mg/dL); hormonal profile: total testosterone (ng/dL),free testosterone (pmol/L), and sex hormone-binding globulin (SHBG) (nmol/L); dietary intake (protein, lipids, and fat); functional performance – short physical performance battery (SPPB) test scores, which range from 1 to 12 points, including balance test, gait test (s), and sit-to-stand test (s); postural balance assessment, dynamic postural balance test measured by Mini balance evaluation systems test (MiniBESTest), which consists of four sections: postural responses, anticipatory postural adjustments, sensory orientation, and dynamic balance during locomotion. Scores range from 0 to 2 for each item, with a maximum of 28; balance test, gait test (s), sit-to-stand test (s), and the time up go (TUG )test with and without a cognitive task (measured in second).

Countries

Brazil

Contacts

Public ContactAngelica Alonso

Universidade São Judas Tadeu

angelicacastilho@msn.com+55(11)999987682

Outcome results

None listed

Source: REBEC (via WHO ICTRP)